IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q4 2022 Holdings

Filed 2023-02-14 | 7 holdings | $179.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mimedx Group, Inc.(MDXG)COM602496101$65.1M23,415,58436.3%
Tela BIO, Inc.(TELA)COM872381108$47.3M4,110,70926.4%
Bioventus(BVS)COM CL A09075A108$31.6M12,096,70217.6%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$14.7M4,190,9218.2%
Venus Concept, Inc.COM92332W105$10.0M31,337,8565.6%
Revance Therapeutics Inc(RVNCEUR)COM761330109$8.4M457,0854.7%
Medicinova Inc(MNOV)COM NEW58468P206$2.3M1,105,9411.3%